Literature DB >> 3966881

Computed tomography in chronic seizure disorder caused by glioma.

K M Rich, S Goldring, M Gado.   

Abstract

Since the introduction of computed tomography (CT) in 1974, 137 patients underwent cortical resection for intractable epilepsy. The CT scans of 32 of these patients demonstrated an isolated calcified or hypodense lesion of unknown origin. The mean interval from onset of the seizure disorder to surgery was 11 years. The referring physicians frequently considered these lesions to be of nonneoplastic origin, which usually delayed surgical management. Twenty-six of the 32 patients, however, proved to have a cerebral glioma, seven showing anaplastic changes. Because the majority of these patients were found to have a neoplasm and especially because the CT scan could not distinguish between a well-differentiated glioma and those with anaplastic changes, we recommend early surgical treatment in patients with chronic seizure disorders who are found to have an isolated lesion of unknown origin on CT scan.

Entities:  

Mesh:

Year:  1985        PMID: 3966881     DOI: 10.1001/archneur.1985.04060010032011

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  3 in total

1.  Glial tumourettes (glial microtumours): their clinical and histopathological manifestations.

Authors:  S Nishio; T Morioka; I Takeshita; M Fukui
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

2.  Surgical treatment of temporal lobe epilepsy: clinical, radiological, and histopathological findings in 178 patients.

Authors:  J Zentner; A Hufnagel; H K Wolf; B Ostertun; E Behrens; M G Campos; L Solymosi; C E Elger; O D Wiestler; J Schramm
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-06       Impact factor: 10.154

3.  Hippocampal neuronal density in temporal lobe epilepsy with and without gliomas.

Authors:  J H Kim; P O Guimaraes; M Y Shen; L M Masukawa; D D Spencer
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.